Search company, investor...
Ceres Nanosciences company logo

Ceres Nanosciences

Founded Year



Grant - VIII | Alive

Total Raised


Last Raised

$1.4M | 6 mos ago

About Ceres Nanosciences

Ceres Nanosciences has developed and commercialized a nanoparticle technology, the Nanotrap, which provides biomarker capture and biofluid sample processing capabilities for a wide array of diagnostic applications and sample handling needs. The company was founded in 2008 and is based in Manassa, Virginia.

Headquarters Location

9460 Innovation Drive

Manassas, Virginia, 20110,

United States


Missing: Ceres Nanosciences's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Ceres Nanosciences's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Ceres Nanosciences

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Ceres Nanosciences is included in 3 Expert Collections, including Medical Devices.


Medical Devices

9,046 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.



1,267 items

Companies involved in the capture, sequencing, and/or analysis of genomic, transcriptomic, proteomic, and/or metabolomic data


Health IT

7,901 items

Ceres Nanosciences Patents

Ceres Nanosciences has filed 4 patents.

The 3 most popular patent topics include:

  • Analytical chemistry
  • Chromatography
  • Dosage forms
patents chart

Application Date

Grant Date


Related Topics



Analytical chemistry, Chromatography, Mass spectrometry, Ion source, Molecular biology


Application Date


Grant Date


Related Topics

Analytical chemistry, Chromatography, Mass spectrometry, Ion source, Molecular biology



Latest Ceres Nanosciences News

New Wastewater Test Kit Helps Labs Automate High-Throughput Sample Processing

Jan 26, 2023

Promega Corporation released a new system designed to help wastewater testing labs scale up their infectious disease surveillance by incorporating two technologies in a single kit. Promega pairs the company’s  Maxwell HT chemistry  with  Ceres Nanosciences’ Nanotrap particles , a technology used for capturing and concentrating low-abundance analytes such as viral particles. Together, these technologies empower labs to purify pathogen nucleic acids from wastewater samples in high-throughput workflows, the company says. “Ceres has a technology that enables concentration of microbes from wastewater that is unique to the market,” says Brandon Krueger, Promega field support scientist, “so it worked quite well for Promega and Ceres to join together to make this a better process overall for wastewater testing labs.” The new system joins a growing Promega portfolio of technologies used for wastewater-based epidemiology, including multiple workflows for purification and amplification of viral nucleic acids. Using the new kit offered by Promega, wastewater testing labs use the Ceres Nanotrap particles to concentrate viral particles present in wastewater samples. Next, labs use the established Maxwell HT chemistry to purify nucleic acids such as DNA and RNA. Those nucleic acids can then be amplified and detected using methods such as quantitative polymerase chain reaction (qPCR) or digital PCR (dPCR), or used in sequencing applications. “As wastewater-based epidemiology has expanded, it has become clear that it is incredibly valuable to pair the reliable and easy-to-use Nanotrap particle concentration method with strong purification methods,” says Robbie Barbero, Ceres chief business officer. “We are very excited that labs can now get the Promega Maxwell HT chemistry and the Nanotrap technology in a single kit.” The kit is designed to be implemented on a variety of automated liquid handlers, allowing labs to save time and resources by automating all necessary preprocessing and postprocessing for detecting viral nucleic acid from wastewater samples via qPCR. Promega Field Support Scientists offer comprehensive support for labs implementing Promega chemistry on any liquid handling platform, including robot programming and process optimization. Share:

Ceres Nanosciences Frequently Asked Questions (FAQ)

  • When was Ceres Nanosciences founded?

    Ceres Nanosciences was founded in 2008.

  • Where is Ceres Nanosciences's headquarters?

    Ceres Nanosciences's headquarters is located at 9460 Innovation Drive, Manassas.

  • What is Ceres Nanosciences's latest funding round?

    Ceres Nanosciences's latest funding round is Grant - VIII.

  • How much did Ceres Nanosciences raise?

    Ceres Nanosciences raised a total of $24.07M.

  • Who are the investors of Ceres Nanosciences?

    Investors of Ceres Nanosciences include National Institutes of Health, Small Business Innovation Research Awards, Paycheck Protection Program, Virginia Catalyst, GreyBird Ventures and 7 more.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.